Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.8B 2.61B 2.27B 2.12B 1.94B 3.66B 249B 3.73B 24.96B 9.78B 124B 9.58B 409B P/E 2026 *
18.8x
P/E 2027 * -
Enterprise Value 9.48B 2.52B 2.19B 2.05B 1.88B 3.55B 241B 3.61B 24.15B 9.46B 120B 9.27B 396B EV / Sales 2026 *
5.86x
EV / Sales 2027 * 5.02x
Free-Float
38.61%
Yield 2026 *
3.2%
Yield 2027 * 3.56%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+2.19%
1 week+1.08%
Current month+2.34%
1 month-7.59%
3 months-9.85%
6 months+0.94%
Current year-1.62%
1 week 134.5
Extreme 134.5
140.4
1 month 134.5
Extreme 134.5
151.5
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
167
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%+1.08%-13.42%+18.24% 2.55B
-1.36%-0.52%+20.48%+72.09% 50.03B
+5.70%+6.46%+64.58%+133.35% 36.6B
+0.08%+4.61%-1.89%+26.47% 12.47B
-0.51%+1.16%+18.12%+75.16% 11.77B
-1.33%-0.57%+30.73%+130.67% 9.04B
-1.13%-4.39%+39.85%-13.75% 7.03B
+1.10%+1.62%+14.71%+33.59% 6.79B
-0.17%+1.55%+7.84%+181.51% 6.6B
-0.24%-0.36%-35.41%+6.58% 5.49B
Average +0.40%+0.84%+14.56%+66.39% 14.84B
Weighted average by Cap. +0.77%+1.27%+27.36%+82.86%

Financials

2026 *2027 *
Net sales 1.62B 430M 374M 349M 321M 605M 41.03B 615M 4.12B 1.61B 20.46B 1.58B 67.49B 1.87B 498M 433M 404M 371M 700M 47.48B 712M 4.77B 1.87B 23.68B 1.83B 78.09B
Net income 521M 139M 121M 113M 103M 195M 13.22B 198M 1.33B 520M 6.59B 509M 21.75B -
Net Debt -317M -84.39M -73.35M -68.48M -62.86M -119M -8.04B -121M -807M -316M -4.01B -310M -13.23B -404M -108M -93.48M -87.27M -80.12M -151M -10.25B -154M -1.03B -403M -5.11B -395M -16.86B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-08-03 SAR 140.00 +2.19% 101,805
26-08-02 SAR 137.00 +0.15% 12,030
26-07-30 SAR 136.80 -0.80% 48,288
26-07-29 SAR 137.90 -2.34% 19,086
26-07-28 SAR 141.20 +1.95% 33,857
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
140.00SAR
Average target price
164.24SAR
Spread / Average Target
+17.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock